Detalhe da pesquisa
1.
Metabolomics as a tool to predict the risk of decompensation or liver-related death in patients with compensated cirrhosis.
Hepatology
; 77(6): 2052-2062, 2023 06 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36811400